| Characteristics |
Frequency n=190 |
Percentage (%) |
|---|---|---|
| Age group | ||
| 30-39 | 3 | 1.58 |
| 40-49 | 30 | 15.79 |
| 50-59 | 63 | 33.16 |
| 60-69 | 64 | 33.68 |
| 7 0 and above | 30 | 15.79 |
| Mean | 59.56 ± 11.66 | |
| Sex | ||
| Male | 91 | 47.89 |
| Female | 99 | 52.11 |
| TOTAL | 190 | 100 |
| Diagnosis | ||
| Retinal vein occlusion | 61 | 32.11 |
| Diabetic macular edema | 43 | 22.63 |
| Proliferative diabetic retinopathy | 42 | 22.11 |
| Neovascular age related macular degeneration | 26 | 13.68 |
| Neovascular glaucoma | 9 | 4.74 |
| Myopic choroidal neovascularization | 3 | 1.58 |
| Cystoid macular edema | 3 | 1.58 |
| Vitreous hemorrhage | 3 | 1.58 |
| TOTAL | 190 | 100 |
| Intraocular Pressure | ||
| Normal | 129 | 67.89 |
| Raised | 61 | 32.11 |
| COMPFLAINTS | ||
| Floaters | 40 | 21.05 |
| Sub conjunctival hemorrhage | 6 | 3.16 |
| Ocular pains | 24 | 12.63 |
| Nil | 120 | 63.16 |
| TOTAL | 190 | 100 |
| INJECTION SITE | ||
| Supero temporal quadrant | 131 | 68.95 |
| Infero temporal quadrant | 44 | 23.16 |
| Supero nasal quadrant | 15 | 7.89 |
| TOTAL | 190 | 100 |